Delivery Order SPE2DB22D3016-SPE2DB25FAYH2

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568161338 - Phenobarbital 65 mg/ml vial. The $3,905.64 firm fixed-price contract has a completion date of May 7, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, valued at $2,190.18, is a delivery order for the supply of Phenobarbital 130 mg/ml vials. The contract has a firm fixed price pricing type and an ultimate completion date of May 20, 2025. This award is not associated with a set-aside program and appears to be part of a...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Phenobarbital 130 mg/ml vials to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,417.38 firm fixed price delivery order (SPE2DB24FL2NU) has an ultimate completion date of August 16, 2024 and is not designated as a set-aside. AmerisourceBergen also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,436.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of PHENOBARBITAL 65 MG/ML VIAL. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to Amerisourcebergen Drug Corp, with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is for the delivery of pharmaceutical products, specifically Phenobarbital 130 mg/ml vials, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,259.34 firm fixed price delivery order has a period of performance through March 27, 2024. Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, is the prime contractor for this award. The company also...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phenobarbital 130 mg/ml vials, a medication used for various medical conditions. The contract has a firm fixed price of $5,283.68 and a performance period ending on May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,683.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, identified as SPE2DX15D1022|SPE2DX25FVEHS, is a delivery order contract for the supply of 4567951747 PHENOBARBITAL 130 MG/ML VIALML. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is a $2,339.82 Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 130 mg/ml vials of Phenobarbital, a medication commonly used to treat seizures and certain types of brain disorders. This contract is not set-aside and is awarded as an open competition. Amerisourcebergen Drug Corp holds a substantial...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,027.94 Firm Fixed Price Delivery Order (SPE2DX15D1022|SPE2DX23FVGVL) is for the supply of Phenobarbital 130 mg/ml vials. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Phenobarbital 130 mg/mL vials. The order has a ceiling value of $1,244.41 and is a firm fixed-price contract with a performance period ending on July 30, 2024. This order is not associated with a set-aside program. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies,...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAYH2
    Delivery Order

This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,561.94 firm-fixed-price delivery order is for the supply of 130 mg/mL vials of the drug Phenobarbital. The contract has an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle for supplying a wide range of pharmaceutical products and medical supplies to military healthcare programs and other government agencies through December 2026. The contract award is not set aside for any specific business type.

Generated 9/3/25, 9:54 AM